Trial Profile
Intravenous Immunoglobulin Therapy in ARDS Patients With Extracorporeal Membrane Oxygenation (ECMO) Therapy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 May 2018
Price :
$35
*
At a glance
- Drugs Immune globulin (Primary)
- Indications Septic shock
- Focus Therapeutic Use
- 13 Oct 2017 New trial record